Motility-mediated drug interactions with GLP-1 receptor agonists: labeled evidence and a framework for quantitative assessment

Jae Yong Chung · 2026

Read Motility-mediated drug interactions with GLP-1 receptor agonists: labeled evidence and a framework for quantitative assessment by Jae Yong Chung (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13645479.txt.

Description

Jae Yong Chung examines a side effect shared by the GLP-1 diabetes and weight drugs: they slow the stomach's emptying. A slower stomach can change how other medicines are absorbed, yet testing for that effect is rare. Chung screened all eleven United States labels for the class, and each one warns about delayed emptying. Only six labels gave numbers, and the direction of change was not uniform: levels of a thyroid drug, a cholesterol drug, and a blood pressure drug each rose under some conditions.

Chung argues the standard testing pipeline, built around liver enzymes and transport proteins, simply never asks about stomach speed. A total exposure measure can hide rate changes that matter for some drugs. He proposes a framework of probe drug panels matched to drug types, study designs that state dosing times plainly, and computer models checked against human stomach data.

Catalog record

CREATORJae Yong Chung
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13645479

Browse the full library · About the Tower of Babel